Actinogen

Actinogen

A biotechnology company engaged in commercialising bioactive compounds.
References in periodicals archive ?
Actinogen Medical (ASX: ACW), an Australian biotech company based in New South Wales, is embarking on a new clinical trial aimed at defeating Alzheimer's disease using unconventional treatments, the Australian Financial Review reported on Tuesday.
For Dr Bill Ketelbey, CEO and managing director of Actinogen Medical, the unusual approach was due to "Alzheimer's [being] one of those diseases where there has to be multiple shots on goals.
We then reverse merged it into an Australian cash shell, Actinogen, thereby giving the asset access to $3m of capital, which will be enough to take it to phase two trials.
27 August 2014 - Australia-based biotechnology firm Actinogen Ltd (ASX:ACW) announced today it had signed an agreement to acquire UK Alzheimer's dementia therapies developer Corticrine Ltd.
Following the transaction, the University of Edinburgh will hold about 11% in Actinogen.
Swansea University is pioneering Europe's five-year multi-million pound ActinoGEN project to find solutions to drug-resistant diseases.
Experts from across Europe were at the University of Wales, Swansea yesterday to officially start the five-year multi-million-pound ActinoGEN project.
But ActinoGEN experts believe there is the potential to create many more.
Australia-based biotechnology firm Actinogen Ltd (ASX:ACW) announced it had signed an agreement to acquire UK Alzheimer's dementia therapies developer Corticrine Ltd.
4 million euro European Union-funded research project, called ActinoGEN.